Switzerland· 65651002
Fulvestrant Sandoz
A fulvestrant product containing fulvestrantum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Fulvestrant is registered in 17 of 19 countries.
Countries holding a registration under ATC L02BA03 (fulvestrant), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 9 of them publish a price we can compare per daily dose
Fulvestrant · ATC L02BA03
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of fulvestrant costs, country by country.
Normalised to the WHO defined daily dose (16.7 mg), so markets compare like for like.
- Switzerland: $13.25 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Fulvestrant · price per daily dose (16.7 mg)
USD · FX 28 Sept 2026
- CH Switzerland$13.25
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- fulvestrantum
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- L02BA03
- ATC class
- Fulvestrant
- Defined daily dose
- 16.7 mg, P
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin76806565100282 Fertspr 5 mlCHF 329.05
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
110 interactions on record for fulvestrant.
Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Fulvestrant · interactions on record
110 records
- 1 moderate
- 109 info
Most severe, free to view
- Omacetaxine mepesuccinateL01XX40moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Fulvestrant in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesfulvestrantSagent Pharmaceuticals
- IrelandFulvestrant Rowex 250 mg/5 ml solution for injection in pre-filled syringeRowex Limited,
- NetherlandsFulvestrant Sandoz 50 mg/ml, oplossing voor injectie in een voorgevulde spuitSandoz B.V.
- GermanyFulvestrant 1 A Pharma1 A Pharma Gmbh
- PolandFaslodexAstraZeneca AB
- CzechiaFASLODEXAstraZeneca AB, Södertälje
- SpainAFULTRANT 250 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFGBexal Farmaceutica S.A.
- FinlandFaslodexAstraZeneca AB
Authorised across Europe · EMA
The same active substance is authorised in 31 EEA countries. Names it is sold under:
- Austria · Fulvestrant +pharma, Fulvestrant Accord
- Belgium · Fulvestrant Accord, Fulvestrant Eugia
- Bulgaria · Fulvestrant Ever Pharma, Fulvestrant Pharmascience
- Cyprus · Fulvestrant Accord, Fulvestrant Rompharm
- Czechia · Fulvestrant Accord, Fulvestrant Ever Pharma
- Germany · Fulvestrant 1 A Pharma, Fulvestrant Abz
- Denmark · Fulvestrant "stada", Fulvestrant Accord
- Estonia · Fulvestrant Accord, Fulvestrant Aliud
- Spain · Afultrant, Ambiful
- Finland · Fulvestrant Accord, Fulvestrant Ever Pharma
- France · Fulvestrant, Fulvestrant Accord
- United Kingdom (Northern Ireland) · Fulvestrant Accord Healthcare, Fulvestrant Dr. Reddy's
- Greece · Fulvestrant Accord, Fulvestrant Demo
- Croatia · Fulvestrant Accord, Fulvestrant Aptapharma
- Hungary · Fulvestrant Aptapharma, Fulvestrant Elc
- Ireland · Fulvestrant Accord Healthcare Ireland, Fulvestrant Ever Pharma
- Iceland · Faslodex, Fulvestrant Accord
- Italy · Fulvestrant Accord, Fulvestrant Aurobindo
- Liechtenstein · Faslodex, Fulvestrant Mylan
- Lithuania · Fulvestrant Aliud, Fulvestrant Orion
- Luxembourg · Fulvestrant Teva
- Latvia · Fulvestrant Aliud, Fulvestrant Stada
- Malta · Fulvestrant Ever Pharma
- Netherlands · Fulvestrant, Fulvestrant Accord
- Norway · Faslodex, Fulvestrant Accord
- Poland · Fulvestrant Eugia, Fulvestrant Ever Pharma
- Portugal · Ambiful, Cykostra
- Romania · Falvax, Fulvestrant Accord
- Sweden · Fulvestrant Accord, Fulvestrant Ever Pharma
- Slovenia · Fulvestrant Accord, Fulvestrant Aptapharma
- Slovakia · Fulvestrant Accord, Fulvestrant Ever Pharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/31a98062-cbcb-4e01-afcb-17df75722b3e GET /v1/drugs/31a98062-cbcb-4e01-afcb-17df75722b3e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "fulvestrantum 250 mg",
"valid_from": "2016-08-01",
"limitations": "[{\"description\":\"Behandlung von postmenopausalen Patientinnen (natürliche oder induzierte Menopause) mit lokal fortgeschrittenem oder metastasierendem Östrogenrezeptor-positivem Mammakarzinom, die auf eine andere antihormonelle Therapie nicht oder nicht mehr ansprechen.\",\"costApproval\":null,\"indication\":null,\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2016-08-01\",\"validTo\":null}]",
"galenic_form": "Inj Lös 250 mg/5ml i.m.",
"therapeutic_area": null,
"sl_inclusion_date": "2016-08-01",
"self_retention_pct": 10
}See everything about fulvestrant.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.